GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cidara Therapeutics Inc (FRA:20D0) » Definitions » E10

Cidara Therapeutics (FRA:20D0) E10 : €-37.68 (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Cidara Therapeutics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Cidara Therapeutics's adjusted earnings per share data for the three months ended in Dec. 2024 was €-5.128. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-37.68 for the trailing ten years ended in Dec. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-03-14), Cidara Therapeutics's current stock price is €18.80. Cidara Therapeutics's E10 for the quarter that ended in Dec. 2024 was €-37.68. Cidara Therapeutics's Shiller PE Ratio of today is .


Cidara Therapeutics E10 Historical Data

The historical data trend for Cidara Therapeutics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cidara Therapeutics E10 Chart

Cidara Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -41.88 -37.68

Cidara Therapeutics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -41.88 -42.53 -38.48 -40.09 -37.68

Competitive Comparison of Cidara Therapeutics's E10

For the Biotechnology subindustry, Cidara Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cidara Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cidara Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Cidara Therapeutics's Shiller PE Ratio falls into.



Cidara Therapeutics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cidara Therapeutics's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-5.128/133.1571*133.1571
=-5.128

Current CPI (Dec. 2024) = 133.1571.

Cidara Therapeutics Quarterly Data

per share eps CPI Adj_EPS
201503 -9.808 99.621 -13.110
201506 -10.514 100.684 -13.905
201509 -11.939 100.392 -15.836
201512 -13.219 99.792 -17.639
201603 -12.752 100.470 -16.901
201606 -15.130 101.688 -19.812
201609 -15.682 101.861 -20.500
201612 -16.685 101.863 -21.811
201703 -14.960 102.862 -19.366
201706 -17.622 103.349 -22.705
201709 -12.249 104.136 -15.663
201712 -11.661 104.011 -14.929
201803 -12.976 105.290 -16.410
201806 -19.346 106.317 -24.230
201809 -8.399 106.507 -10.501
201812 -7.735 105.998 -9.717
201903 -10.266 107.251 -12.746
201906 -8.319 108.070 -10.250
201909 1.453 108.329 1.786
201912 -7.560 108.420 -9.285
202003 -8.326 108.902 -10.180
202006 -7.992 108.767 -9.784
202009 -6.962 109.815 -8.442
202012 -8.056 109.897 -9.761
202103 -6.552 111.754 -7.807
202106 2.988 114.631 3.471
202109 -6.290 115.734 -7.237
202112 -4.602 117.630 -5.209
202203 -4.903 121.301 -5.382
202206 -3.595 125.017 -3.829
202209 3.434 125.227 3.651
202212 -3.587 125.222 -3.814
202303 0.560 127.348 0.586
202306 -2.787 128.729 -2.883
202309 -1.893 129.860 -1.941
202312 -0.633 129.419 -0.651
202403 -2.098 131.776 -2.120
202406 -18.571 132.554 -18.656
202409 -2.207 133.029 -2.209
202412 -5.128 133.157 -5.128

Add all the adjusted EPS together and divide 10 will get our e10.


Cidara Therapeutics  (FRA:20D0) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Cidara Therapeutics E10 Related Terms

Thank you for viewing the detailed overview of Cidara Therapeutics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Cidara Therapeutics Business Description

Traded in Other Exchanges
Address
6310 Nancy Ridge Drive, Suite 101, San Diego, CA, USA, 92121
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

Cidara Therapeutics Headlines

No Headlines